Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$53

Avg closing price
Price range

10 John W. Rogers Jr. Astrazeneca plc Trades

The first Astrazeneca plc trade was made in Q4 2020. Since then John W. Rogers Jr. bought shares two more times and sold shares on seven occasions. The investor sold all their shares in Q1 2023 and doesn't own any shares in Astrazeneca plc anymore.

Avg closing price
Price range
Sold -22.4 Thousand shares Q1 2023
Avg closing price $67.27
Price range $63.15 - $71.60
Increased shares by 1.6% (+348 shares) Q4 2022
Avg closing price $62.70
Price range $54.21 - $70.44
Sold 2.8% shares (-636 shares) Q3 2022
Avg closing price $63.43
Price range $53.02 - $68.26
Sold 5.3% shares (-1.26 Thousand shares) Q2 2022
Avg closing price $65.61
Price range $59.26 - $71.14
Sold 3.2% shares (-796 shares) Q1 2022
Avg closing price $59.96
Price range $55.72 - $67.12
Sold 6.1% shares (-1.61 Thousand shares) Q4 2021
Avg closing price $58.83
Price range $54.02 - $63.83
Sold 0.3% shares (-75 shares) Q3 2021
Avg closing price $58.20
Price range $55.56 - $60.79
Sold 1.4% shares (-368 shares) Q2 2021
Avg closing price $54.86
Price range $48.42 - $60.18
Increased shares by 1.5% (+385 shares) Q1 2021
Avg closing price $50.26
Price range $47.16 - $54.44
New holding (+26.4 Thousand shares) Q4 2020
Avg closing price $52.96
Price range $48.52 - $58.02

News about Astrazeneca plc - ADR and John W. Rogers Jr.

AstraZeneca PLC Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Against AZN

AstraZeneca PLC Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Against AZN

SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchas...

accesswire.com accesswire.com, 4 months ago
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

NEW ORLEANS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., re...

globenewswire.com globenewswire.com, 4 months ago
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

NEW ORLEANS, LA / ACCESSWIRE / January 6, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., ...

accesswire.com accesswire.com, 4 months ago
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN

NEW ORLEANS , Jan. 3, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind...

prnewswire.com prnewswire.com, 4 months ago

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!